Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Angelina Jolie Mastectomy: Her Amazing Story
Angelina Jolie Mastectomy: Her Amazing Story 5

 This was because she had the BRCA1 gene mutation. This mutation made her very likely to get breast cancer. The amazing story of the Angelina Jolie mastectomy. Learn why she made the brave choice and how it changed the conversation on genetic risk.

 We will also talk about what a preventive double mastectomy is. This surgery is a big step for women who think they might get breast cancer.

Key Takeaways

  • A preventive double mastectomy is a surgery to remove both breasts to stop breast cancer.
  • The BRCA1 gene mutation makes a person very likely to get breast cancer.
  • Celebrities like Angelina Jolie can change how people think about stopping breast cancer.
  • It’s important to understand why someone might choose this surgery. This helps both patients and doctors.
  • Getting care that fits you and having support is key for those thinking about preventive steps.

Overview of Angelina Jolie’s Health Choices

Angelina Jolie Mastectomy: Her Amazing Story
Angelina Jolie Mastectomy: Her Amazing Story 6

The Role of Genetics in Health Decisions

Public Reaction to Her Announcement

Aspect

Description

Impact

Genetic Testing

Revealed BRCA1 gene mutation

Informed decision for preventive mastectomy

Family History

Influenced decision-making

Public Reaction

Increased awareness and inquiries about genetic testing

Led to more women seeking counseling and testing

What is a Double Mastectomy?

Angelina Jolie Mastectomy: Her Amazing Story
Angelina Jolie Mastectomy: Her Amazing Story 7

A double mastectomy, also known as prophylactic mastectomy, is a surgery to remove both breasts. It’s a big choice for women at high risk of breast cancer. This is often the case for those with BRCA1 or BRCA2 gene mutations.

Definition of the Procedure

The double mastectomy procedure removes both breasts. There are different types, like simple mastectomy and skin-sparing mastectomy. Simple mastectomy removes the whole breast, while skin-sparing keeps the skin for reconstruction.

The surgery is done under general anesthesia. It can take several hours. This depends on how complex the surgery is and if reconstruction is done at the same time.

Reasons for Choosing This Surgery

Women choose double mastectomy for several reasons. The main reason is to lower their risk of breast cancer. Key factors include:

  • Genetic predisposition: Women with BRCA1 or BRCA2 gene mutations are at higher risk and may opt for preventive surgery.
  • Family history: A strong family history of breast cancer can prompt women to consider mastectomy.
  • Previous breast cancer: Women who have had breast cancer in one breast may choose to have the other breast removed as a preventive measure.

Description

Risk Reduction

Genetic Predisposition

Presence of BRCA1 or BRCA2 gene mutations

Up to 90% reduction

Family History

Multiple first-degree relatives with breast cancer

Significant reduction, varies by individual risk factors

History of breast cancer in one breast

Reduces risk in the other breast

Angelina Jolie’s Personal Experience
AD 4nXe3tIvoo9iuvm ITnOXomjixBHbYoXwtNb2fv1i B7IGKHqcDzPlzMvawKeewQUJVC lb0l1CXx3vlaUf5GLqyscRR 6utQ9zBzEghtBvuG1VYHEL3oY2KlTSSZCyqjIpLfXAM DRMtJSaG?key=EYBGwtX8MNF39iV2bgdEFA LIV Hospital

er BRCA1 gene mutation. Her decision highlighted the need for genetic testing and preventive measures against breast cancer.

 She said, “I chose not to keep my story private because there are so many women who do not know that they might be living under the shadow of cancer.” This shows her proactive approach to her genetic risk.

Motivations and Concerns

 She said, “My mother fought cancer for almost a decade, and she died at 56. She was a fighter, but she had so much life in her. I feel a strong sense of responsibility to be proactive about my own health and to share my experience with others.”

Motivations

Concerns

Potential risks associated with surgery

BRCA1 gene mutation

Emotional and physical recovery

Desire to reduce cancer risk

Impact on personal and family life

The Impact of Angelina’s Decision

 It has made people more aware of breast cancer and the need for preventive surgeries.

Influence on Breast Cancer Awareness

Her announcement sparked a rise in genetic testing and talks about preventive measures. This is known as the “Angelina Jolie effect.” It shows how famous people’s health choices can change public health actions.

Changes in Perceptions of Preventive Surgeries

Angelina Jolie’s surgery made more women think about their health risks. They started talking about preventive surgeries more. This is because of the growing awareness of genetic breast cancer risks.

Year

Number of Women Seeking Genetic Testing

Percentage Increase

2012

10,000

2013

15,000

50%

2014

20,000

33%

Genetic Testing and Its Importance

Understanding BRCA1 and BRCA2 Gene Mutations

BRCA1 and BRCA2 genes fix DNA damage. Mutations in these genes increase breast and ovarian cancer risks. Women with a family history of these cancers might want to get tested.

Informing Health Decisions Through Genetic Testing

Genetic testing gives important info for health choices. It helps women and doctors decide on screenings, treatments, and surgeries. Those with BRCA1 or BRCA2 mutations might choose mastectomy or other preventive steps.

Gene Mutation

Associated Cancer Risks

Potential Preventive Measures

BRCA1

Breast, Ovarian

Enhanced screening, Risk-reducing mastectomy, Chemoprevention

BRCA2

Breast, Ovarian, Prostate

Enhanced screening, Risk-reducing mastectomy, Chemoprevention

Knowing genetic risks helps women manage their health. Genetic counseling is key. It offers support and guidance in making health choices.

The Recovery Process After a Mastectomy

After a mastectomy, patients start a journey of healing. This journey includes getting back physically and emotionally. Each person’s recovery is different, based on the surgery and their health.

Physical Recovery Timeline

The time it takes to recover from a mastectomy varies. Right after surgery, rest and managing pain are key. Patients should not lift heavy things or do strenuous activities.

  • Initial recovery phase (1-2 weeks): Focus on rest, pain management, and wound care.
  • Intermediate phase (2-6 weeks): Gradually resume normal activities, with continued avoidance of heavy lifting.
  • Late recovery phase (6 weeks and beyond): Return to most normal activities, with some restrictions on strenuous exercises.

It’s important to follow your doctor’s advice for a smooth recovery. Proper wound care and watching for infection signs are critical.

Emotional and Psychological Support

Emotional and psychological support is just as important as physical care. Patients may feel many emotions, from relief to anxiety and depression. Support systems include family, friends, support groups, and professional counseling.

We know a full care approach is key. This includes:

  1. Access to counseling services to address emotional and psychological needs.
  2. Support groups where patients can share their experiences and connect with others.
  3. Educational resources to inform patients about their recovery and what to expect.

By combining these elements, patients can better handle their recovery. They can deal with both physical and emotional healing after a mastectomy.

Mastectomy isn’t the only choice for women at high risk of breast cancer. Other preventive steps are available. For those not ready or willing for mastectomy, there are other options to consider.

Regular Screenings and Monitoring

Regular screenings and monitoring are key alternatives to mastectomy. This includes:

  • Annual mammograms to catch problems early.
  • Regular breast MRI scans for detailed images, good for dense breasts.
  • Clinical breast exams by a doctor.

Screenings help find cancer early, which can lead to better treatment results. It’s vital to stick to a screening plan that fits your risk level.

Other Preventive Measures

There are more ways to prevent breast cancer. These include:

  • Chemoprevention: Taking medicines like tamoxifen or raloxifene to lower cancer risk.
  • Lifestyle changes: Keeping a healthy weight, exercising, and drinking less alcohol can help breast health.
  • Risk-reducing medications: Some women might be advised to take certain drugs to lower their risk.

Women should talk to their doctor about these options. This helps find the best choice based on their risk and health.

Exploring these alternatives lets women at high risk make informed health choices. They can weigh the pros and cons of each option.

Angelina’s Advocacy and Activism

Raising Awareness for Breast Cancer

Year

Event

Impact

2013

Increased awareness about BRCA gene mutations

2015

Angelina Jolie undergoes preventive ovarian surgery

Raised awareness about ovarian cancer risks

Supporting Other Women with Similar Experiences

Angelina Jolie has also focused on supporting women who have gone through similar experiences. She has highlighted the stories of other survivors and provided resources for those thinking about preventive measures. This has built a supportive community.

“The most important thing I can do is to speak out loudly and clearly, to make sure that no one else is ever in the same situation I was in.”

Angelina Jolie

Conclusion: The Legacy of Angelina Jolie’s Choice

we talk about women’s health. Her decision is very important for women with BRCA gene mutations. They are at a higher risk of getting breast cancer.

Impact on Women’s Health Discussions

Future Implications for Preventive Care

We need to keep supporting women with the care they need. It’s important to offer personalized medical support. This way, women at high risk can make informed decisions about their health.

FAQ

What is a double mastectomy?

A double mastectomy is a surgery where both breasts are removed. It’s often done to prevent breast cancer. This is common for women with BRCA1 or BRCA2 gene mutations.

What is the role of genetic testing in health decisions?

Genetic testing, like for BRCA1 and BRCA2, is key in health choices. It helps find people at high risk of breast and ovarian cancer. This lets them think about preventive steps like mastectomy or more screening.

What are the benefits and risks of a double mastectomy?

A double mastectomy can greatly lower breast cancer risk. But, it also has risks. These include surgery problems, emotional effects, and possible issues with reconstruction.

What is the recovery process like after a mastectomy?

After a mastectomy, recovery varies. It also needs emotional and psychological support. This shows the need for full care during this time.

Are there alternatives to mastectomy for breast cancer prevention?

Yes, there are other options. These include regular checks and monitoring. Also, chemoprevention or more watchful care can be options, based on risk and preference.

How has Angelina Jolie’s decision impacted breast cancer awareness?

t’s made people talk more about breast cancer, genetic testing, and preventive surgeries. It has also influenced health choices.

What is the significance of genetic counseling in making health decisions?

Genetic counseling is very important. It helps understand the risks and benefits of genetic testing. It guides health choices based on test results.

How does a BRCA gene mutation affect breast cancer risk?

A BRCA1 or BRCA2 mutation greatly raises the risk of breast and ovarian cancer. This makes mastectomy or more screening important for those with the mutation.

What support is available for women who have undergone a mastectomy?

Women after a mastectomy can get many kinds of support. This includes emotional and psychological help, support groups, and resources for recovery. It shows the need for full care.


References

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408206/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01